Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polfarmex
Kutno, Łódzkie, Polandpolfarmex.pl ↗
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
01
Overview
Polfarmex is a leading Polish manufacturer of generic drugs with over 100 products available in Poland, Central and Eastern Europe, the Baltics, and the Far East; since 2017, it has engaged in R&D for biosimilars, focusing particularly on insulin analogues[2][3][4].
- Therapeutic areas
- PsychiatryGastroenterologyDermatologyPulmonologyCardiovascularNeurologyWomen's Health
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Mabion (historical founding partner)
Beyond the preview
Go deeper on Polfarmex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polfarmex.